Pain Management-Focused Penny Stock Virpax Pharmaceuticals Surges Over 100% On Wednesday-Here's Why? [Yahoo! Finance]
Virpax Pharmaceuticals, Inc. (VRPX)
Company Research
Source: Yahoo! Finance
bupivacaine formulation injected at a wound site to provide immediate and extended pain relief Shares are trading on a strong session volume of over 100 million, as per data from Benzinga Pro The pharmacokinetics (PK) and safety study of Probudur in the Swine Model was designed to determine the PK profile of Probudur and to ascertain any adverse effects on the pigs. Probudur was subcutaneously injected into four juvenile domestic pigs at a dose of 30 mg/kg and was well-tolerated by all of the pigs and demonstrated a long-term, slow-release profile. Histopathology was also conducted at the injection site, and Probudur was well-tolerated by all pigs in this study. “Our study results to date for Probudur, as expected, have consistently been positive and support our belief that Probudur has the potential to provide both immediate relief as well as sustained relief at the wound site,” stated Gerald Bruce, CEO of Virpax Pharmaceuticals. “With our agreement to negotiate additiona
Show less
Read more
Impact Snapshot
Event Time:
VRPX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VRPX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VRPX alerts
High impacting Virpax Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
VRPX
News
- Virpax Pharmaceuticals Reports 2024 Second Quarter Results and Recent DevelopmentsBusiness Wire
- Virpax Pharmaceuticals to Present at Sidoti Virtual Investor Conference August 14-15 [Yahoo! Finance]Yahoo! Finance
- Virpax Pharmaceuticals to Present at Sidoti Virtual Investor Conference August 14-15Business Wire
- Virpax Regains Compliance with Nasdaq Minimum Bid PriceBusiness Wire
- Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) was upgraded by analysts at Maxim Group from a "hold" rating to a "buy" rating. They now have a $3.00 price target on the stock.MarketBeat
VRPX
Sec Filings
- 9/17/24 - Form 8-K
- 8/13/24 - Form S-1/A
- 8/13/24 - Form 8-K
- VRPX's page on the SEC website